REPLIGEN CORP Public Float
REPLIGEN CORP (RGEN) had Public Float of $6.00 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $6.00B.
- 2024-06-30: Entity Public Float $5.98B.
- 2023-06-30: Entity Public Float $6.93B.
- 2022-06-30: Entity Public Float $8.91B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $6.00B 10-K · filed 2026-02-26 |
| 2024-06-30 | $5.98B 10-K · filed 2025-03-14 |
| 2023-06-30 | $6.93B 10-K/A · filed 2024-11-18 |
| 2022-06-30 | $8.91B 10-K · filed 2023-02-22 |
| 2021-06-30 | $10.86B 10-K · filed 2022-02-17 |
| 2020-06-30 | $5.71B 10-K · filed 2021-02-24 |
| 2019-06-28 | $3.60B 10-K · filed 2020-02-26 |
| 2018-06-29 | $1.57B 10-K · filed 2019-03-01 |
| 2017-06-30 | $1.23B 10-K · filed 2018-02-22 |
| 2016-06-30 | $915.06M 10-K · filed 2017-02-23 |
| 2015-06-30 | $1.35B 10-K · filed 2016-02-25 |
| 2014-06-30 | $744.29M 10-K · filed 2015-03-17 |
| 2013-06-28 | $262.15M 10-K · filed 2014-03-14 |
| 2012-06-30 | $126.34M 10-K · filed 2013-03-15 |
| 2011-09-30 | $100.13M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |